Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Glycemic control using intermittently scanned continuous glucose monitoring in patients with diabetes requiring methylprednisolone therapy for severe COVID-19
Here is the honest breakdown
Have a BMI equal to or greater than 27, with at least one weight-related health condition like type 2 diabetes or hypertension
The commercial name has not been finalized, though internal Lilly documentation has referenced "Orfoglipron" for the oral GLP-1 separately
Headaches, rashes, and itching
US$ 24.49
US$ 27.31
US$ 28.89
US$ 26.15
US$ 27.80
US$ 27.91
